Memantine Hydrochloride NDC 33342-066

NDC codes

FDA NDC Directory

Product NDC (as listed)33342-066Labeler and product segments. Claims need a package NDC.

Product NDC at billing width33342-0066Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
33342-066-28	33342006628	240 mL in 1 BOTTLE (33342-066-28)Marketed from Oct 13, 2015

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Memantine Hydrochloride
Generic name (nonproprietary): memantine hydrochloride
Active ingredients: Memantine hydrochloride — 2 mg/mL
Dosage form: Solution
Route: Oral
Labeler: Macleods Pharmaceuticals Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 202790
Marketing start: Oct 13, 2015
Listing expires: Dec 31, 2026
Other FDA classes: NMDA Receptor Antagonists (Mechanism)
Identifiers: Product ID 33342-066_0cc19195-8ba3-473e-aa2c-3bf990882db7SPL ID 0cc19195-8ba3-473e-aa2c-3bf990882db7SPL set ID 42f0a9f2-4aa4-46fb-bc24-d3df843bb906RxCUI 996740UNII JY0WD0UA60UPC 0333342066282
Pharmacologic class: N-methyl-D-aspartate Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N433342006628 followed by a unit qualifier and the quantity

Package 33342-0066-28. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 9, 2023.

Indications (excerpt from the label)

Memantine hydrochloride solution is indicated for the treatment of moderate to severe dementia of the Alzheimer's type. Memantine hydrochloride, USP is an N-methyl-D-aspartate (NMDA) receptor antagonist indicated for the treatment of moderate to severe dementia of the Alzheimer's type.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)